These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24339964)

  • 1. Association between human urotensin II and essential hypertension--a 1:1 matched case-control study.
    Peng H; Zhang M; Cai X; Olofindayo J; Tan A; Zhang Y
    PLoS One; 2013; 8(12):e81764. PubMed ID: 24339964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentration of urotensin II is raised in hypertension.
    Cheung BM; Leung R; Man YB; Wong LY
    J Hypertens; 2004 Jul; 22(7):1341-4. PubMed ID: 15201550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of cerebrospinal fluid and plasma urotensin II concentrations in normotensive and hypertensive patients undergoing urological surgery during spinal anesthesia: a pilot study.
    Thompson JP; Watt P; Sanghavi S; Strupish JW; Lambert DG
    Anesth Analg; 2003 Nov; 97(5):1501-1503. PubMed ID: 14570674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum urotensin II levels in patients with non-dipper hypertension.
    Erbay AR; Meric M; Alacam H; Zengin H; Akin F; Okuyucu A; Yuksel S; Soylu K; Gedikli O
    Clin Exp Hypertens; 2013; 35(7):506-11. PubMed ID: 23301552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urotensin-II, oxidative stress, and inflammation increase in hypertensive and resistant hypertensive patients.
    Guler EM; Gokce M; Bacaksiz A; Kocyigit A
    Clin Exp Hypertens; 2021 Apr; 43(3):211-216. PubMed ID: 33172302
    [No Abstract]   [Full Text] [Related]  

  • 6. Exercise urotensin II dynamics in myocardial infarction survivors with and without hypertension.
    Rdzanek A; Filipiak KJ; Karpiński G; Grabowski M; Opolski G
    Int J Cardiol; 2006 Jun; 110(2):175-8. PubMed ID: 16198012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum salusin-alpha levels are decreased and correlated negatively with carotid atherosclerosis in essential hypertensive patients.
    Watanabe T; Suguro T; Sato K; Koyama T; Nagashima M; Kodate S; Hirano T; Adachi M; Shichiri M; Miyazaki A
    Hypertens Res; 2008 Mar; 31(3):463-8. PubMed ID: 18497465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urotensin-II system in genetic control of blood pressure and renal function.
    Debiec R; Christofidou P; Denniff M; Bloomer LD; Bogdanski P; Wojnar L; Musialik K; Charchar FJ; Thompson JR; Waterworth D; Song K; Vollenweider P; Waeber G; Zukowska-Szczechowska E; Samani NJ; Lambert D; Tomaszewski M
    PLoS One; 2013; 8(12):e83137. PubMed ID: 24391740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The expression and significance of urotensin II, nitric oxide, and C-type natriuretic peptide in hypoxia-induced pulmonary hypertension in rats].
    Sun DJ; Yang JP; Sun YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Mar; 29(3):185-8. PubMed ID: 16677483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of CBD supplementation on ambulatory blood pressure and serum urotensin-II concentrations in Caucasian patients with essential hypertension: A sub-analysis of the HYPER-H21-4 trial.
    Kumric M; Dujic G; Vrdoljak J; Supe-Domic D; Bilopavlovic N; Dolic K; Dujic Z; Bozic J
    Biomed Pharmacother; 2023 Aug; 164():115016. PubMed ID: 37321059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma urotensin II as a marker for severity of rheumatic valve disease.
    Ozer O; Davutoglu V; Ercan S; Akcay M; Sari I; Sucu M; Celik A; Aksoy N; Cicek H; Al B
    Tohoku J Exp Med; 2009 May; 218(1):57-62. PubMed ID: 19398874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expressions of irisin and urotensin II and their relationships with blood pressure in patients with preeclampsia.
    Zhang LJ; Xie Q; Tang CS; Zhang AH
    Clin Exp Hypertens; 2017; 39(5):460-467. PubMed ID: 28534711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The upregulation of endothelial nitric oxide synthase and urotensin-II is associated with pulmonary hypertension and vascular diseases in rats produced by aortocaval shunting.
    Qi J; Du J; Tang X; Li J; Wei B; Tang C
    Heart Vessels; 2004 Mar; 19(2):81-8. PubMed ID: 15042392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between essential hypertension and three vasoactive peptides, urotensin II, endothelin and adrenomedullin.
    Zhu L; Sui L; Wu S; Wang L; Fu J; Wang X
    Clin Exp Hypertens; 2015; 37(7):604-8. PubMed ID: 26207882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin vasodilator effect of exogenous urotensin-II in hypertensives not exposed to antihypertensive medication.
    Rossi M; Magagna A; Di Maria C; Franzoni F; Taddei S; Santoro G
    Blood Press; 2008; 17(1):18-25. PubMed ID: 18568688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The urotensin system is up-regulated in the pre-hypertensive spontaneously hypertensive rat.
    Forty EJ; Ashton N
    PLoS One; 2013; 8(12):e83317. PubMed ID: 24340095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central cardiovascular action of urotensin II in spontaneously hypertensive rats.
    Lin Y; Tsuchihashi T; Matsumura K; Fukuhara M; Ohya Y; Fujii K; Iida M
    Hypertens Res; 2003 Oct; 26(10):839-45. PubMed ID: 14621188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the nitric oxide/L-arginine and sympathetic nervous systems on the vasodepressor action of human urotensin II in anesthetized rats.
    Abdelrahman AM; Pang CC
    Life Sci; 2002 Jul; 71(7):819-25. PubMed ID: 12074941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vivo effects of human urotensin II in the rabbit and rat pulmonary circulation: effects of experimental pulmonary hypertension.
    Deuchar GA; Morecroft I; Dempsie Y; Herold N; Nilsen M; Hicks MN; MacLean MR
    Eur J Pharmacol; 2006 May; 537(1-3):135-42. PubMed ID: 16631735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urotensin II levels in patients with chronic kidney disease and kidney transplants.
    Hursitoglu M; Tukek T; Cikrikcioglu MA; Kara O; Kazancioglu R; Ozkan O; Cakirca M; Akdogan F; Gundogan E; Aydin S; Beycan I; Gursu M; Dogan S; Erek A
    Ups J Med Sci; 2012 Mar; 117(1):22-7. PubMed ID: 22098077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.